APPLICATION
ANDA077673
TYPE
ANDA
ORIGINAL APPROVAL
2018-09-21
LATEST ACTION
2024-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
EFAVIRENZPrescription
EFAVIRENZ 600MG · TABLET · ORAL
Approval history
2024-06-18Labeling · Supplement 21 · standardAP
2020-02-04Labeling · Supplement 16 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.